Page 324 - IJB-10-6

International Journal of Bioprinting Bioprinted plasma biocarriers for MSC delivery

28. Jeyaraman M, Muthu S, Ganie PA. Does the source of customizable microcarriers in vertical wheel bioreactors
mesenchymal stem cell have an effect in themanagement that improve direct visualization, product harvest, and cost.
of osteoarthritis of the knee? Meta-analysis of randomized Cytotherapy. 2024;26(4):372-382.
controlled trials. Cartilage. 2021;13:1532S. doi: 10.1016/j.jcyt.2024.01.009
doi: 10.1177/1947603520951623
38. Kusuma GD, Carthew J, Lim R, Frith JE. Effect of the
29. Hurley ET, Sherman SL, Stokes DJ, et al. Experts achieve microenvironment on mesenchymal stem cell paracrine
consensus on a majority of statements regarding platelet- signaling: opportunities to engineer the therapeutic effect.
rich plasma treatments for treatment of musculoskeletal Stem Cells Dev. 2017;26:617-631.
pathology. Arthroscopy. 2024;40:470-477.e1. doi: 10.1089/scd.2016.0349
doi: 10.1016/j.arthro.2023.08.020
39. Iseki T, Rothrauff BB, Kihara S, et al. Enhanced osteochondral
30. Nurden AT. Platelets, inflammation and tissue regeneration. repair by leukocyte-depleted platelet-rich plasma in
Thromb Haemost. 2011;105(Suppl 1):S13-33. combination with adipose-derived mesenchymal stromal
doi: 10.1160/THS10-11-0720 cells encapsulated in a three-dimensional photocrosslinked
31. Schol J, Tamagawa S, Volleman TNE, Ishijima M, Sakai D. injectable hydrogel in a rabbit model. Stem Cell Res. Ther.
A comprehensive review of cell transplantation and platelet‐ 2024;15(1):159.
rich plasma therapy for the treatment of disc degeneration‐ doi: 10.1186/S13287-024-03750-z
related back and neck pain: a systematic evidence‐based 40. Cuesta-Gomez N, Graham GJ, Campbell JDM. Chemokines
analysis. JOR Spine. 2024;7(2):e1348. and their receptors: predictors of the therapeutic potential
doi: 10.1002/JSP2.1348 of mesenchymal stromal cells. J Transl Med. 2021;
32. Abbadessa A, Ronca A, Salerno A. Integrating bioprinting, 19(1):1-10.
cell therapies and drug delivery towards in vivo regeneration doi: 10.1186/s12967-021-02822-5
of cartilage, bone and osteochondral tissue. Drug Deliv 41. Burnouf T, Chou ML, Lundy DJ, Chuang EY, Tseng CL,
Transl Res. 2024;14:858-894. Goubran H. Expanding applications of allogeneic platelets,
doi: 10.1007/s13346-023-01437-1
platelet lysates, and platelet extracellular vesicles in cell
33. Acebes-Huerta A, Martínez-Botía P, Carbajo-Argüelles G, therapy, regenerative medicine, and targeted drug delivery.
et al. Characterization of the molecular composition and in J Biomed Sci. 2023;30:79.
vitro regenerative capacity of platelet-based bioproducts and doi: 10.1186/S12929-023-00972-w
related subfractions. Acta Biomater. 2024;177(3):132-147.
doi: 10.1016/j.actbio.2024.01.029 42. Noronha NDC, Mizukami A, Caliári-Oliveira C, et al.
Correction to: priming approaches to improve the efficacy
34. Piao Y, You H, Xu T, et al. Biomedical applications of gelatin of mesenchymal stromal cell-based therapies. Stem Cell Res
methacryloyl hydrogels. Eng Regen. 2021;2:47-56. Ther. 2019;10(1):132.
doi: 10.1016/j.engreg.2021.03.002 doi: 10.1186/S13287-019-1259-0
35. Kurian AG, Singh RK, Patel KD, Lee JH, Kim HW. 43. Lu P, Ruan D, Huang M, et al. Harnessing the potential of
Multifunctional GelMA platforms with nanomaterials for hydrogels for advanced therapeutic applications: current
advanced tissue therapeutics. Bioact Mater. 2022;8:267-295. achievements and future directions. Signal Transduct Target
doi: 10.1016/j.bioactmat.2021.06.027 Ther. 2024;9(1):166.
36. Gu Y, Miao F, Liu K, et al. Fabrication of gelatin methacryloyl/ doi: 10.1038/s41392-024-01852-x
graphene oxide conductive hydrogel for bone repair. 44. Cruz EM, Machado LS, Zamproni LN, et al. A gelatin
J Biomater Sci Polym Ed. 2023;34:2076-2090. methacrylate-based hydrogel as a potential bioink for 3d
doi: 10.1080/09205063.2023.2217063
bioprinting and neuronal differentiation. Pharmaceutics.
37. Haskell A, White BP, Rogers RE, et al. Scalable manufacture 2023;15(2):627.
of therapeutic mesenchymal stromal cell products on doi: 10.3390/pharmaceutics15020627

Volume 10 Issue 6 (2024) 316 doi: 10.36922/ijb.4426